For health-care providers and medtech manufacturers alike, the decade ahead will require a coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market-entry criterion, but companies will have to adapt to evolving health-care models. The stakes are high. Will manufacturers be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?

The 5^th annual journée start-up innovantes du dispositif médical was officially opened by French secretary of state Agnès Pannier-Runacher, who has first-hand experience of the benefits of health-tech innovation. She listed the challenges that innovative start-ups must surmount.

The Swedish liquid biopsy start-up expects to be the first company to secure US FDA approval for a metabolism-based urine test for the early detection of kidney cancer in post-surgery patients.